A small group of Australian mesothelioma patients have reportedly lived more than twice as long as expected with a combination of standard chemotherapy and immune system manipulation with the CD40 protein. The CD40 protein plays a role in a broad range of immune and inflammatory responses in the body. Studies in mice have found that activating CD40 with an activating antibody may work “synergistically” with … Continue reading Long Term Mesothelioma Survival with Immune System Activation
Get your free copy of
“Surviving Mesothelioma” Today!